Clinical Trial Update: Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib

View source ↗

Summary

The document reports a completed clinical trial evaluating cognitive function in patients treated with sunitinib or sorafenib for metastatic renal cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Renal Cell Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)
• Sutent (sunitinib)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Metastatic Renal Cell Cancer, GIST | Status: COMPLETED